Name two topical antimicrobial agents used for burn wounds and one advantage or limitation of each.

• A. Silver sulfadiazine: broad coverage but slower epithelialization; mafenide acetate: penetrates eschar and helps deep burns but can cause metabolic acidosis and pain
• B. Silver sulfadiazine: accelerates epithelialization; mafenide acetate: penetrates eschar with no side effects
• C. Silver sulfadiazine: limited antimicrobial coverage; mafenide acetate: does not penetrate eschar
• D. Silver sulfadiazine: acts only on superficial burns; mafenide acetate: reduces pain

Answer: (A)

Understanding topical antimicrobials for burns hinges on balancing infection control with how the agent affects wound healing and tissue penetration. Silver sulfadiazine offers broad antimicrobial coverage across many organisms and is easy to apply, which makes it a common choice for superficial burns. However, it can slow epithelialization because silver compounds can be toxic to keratinocytes and fibroblasts involved in wound healing, and it doesn’t penetrate necrotic eschar well, limiting its effectiveness for deeper burns or infections beneath the eschar.

Mafenide acetate, on the other hand, penetrates eschar and reaches deeper burn tissues, making it useful for preventing and treating infections in deeper burns, including Pseudomonas. The trade-off is notable: it can cause metabolic acidosis due to carbonic anhydrase inhibition and is associated with pain and other discomfort during application and dressing changes, along with potential electrolyte disturbances.

So the combination described—one agent with broad coverage but slower healing, and another that penetrates eschar for deeper infection but with metabolic and pain-related drawbacks—best reflects the typical advantages and limitations of these two topical agents. The other options misstate either the healing effect, the depth of penetration, or the side effect profile of these agents.